Reaction of sleep-wakefulness cycle to stress is related to differences in hypothalamo-pituitary-adrenal axis reactivity in rat

Brain Research

Volumn 804, Issue 1, 1998, Pages 114-124

  Bouyer, J J ^a   Vallee M ^a   Deminiere J M ^a   Le Moal, M ^a   Mayo, W ^a  

^a INSERM   (France)

Author keywords

Corticosterone; Individual differences; Locomotor reactivity to novelty; Sleep wakefulness cycle; Stress

Indexed keywords

CORTICOSTERONE; GLUCOCORTICOID;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMOBILIZATION STRESS; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REM SLEEP; SLEEP WAKING CYCLE; SLOW WAVE SLEEP;

ANIMALS; BEHAVIOR, ANIMAL; CORTICOSTERONE; EXPLORATORY BEHAVIOR; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; IMMOBILIZATION; MALE; MOTOR ACTIVITY; PITUITARY-ADRENAL SYSTEM; RATS; RATS, SPRAGUE-DAWLEY; SLEEP STAGES; STRESS; WAKEFULNESS;

EID: 0032584912     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)00670-2     Document Type: Article

References (45)

1. M.V. Ambrosini, G. Mariucci, L. Colarieti, G. Bruschelli, C. Carobi, A. Giuditta, The structure of sleep is related to the learning ability of rats, Eur. J. Neurosci. 5 (1993) 269-275.
2. O. Benoit, J. Foret, B. Merle, A. Reinberg, Circadian rhythms (temperature, heart rate, vigilance, mood) of short and long sleepers: effect of sleep deprivation, Chronobiologia 8 (1981) 350.
3. 18-39) brain contents in the rat, Brain Res. 751 (1997) 54-63.
4. J. Born, W. Kern, K. Bieber, G. Fehm-Wolfsdorf, M. Schiebe, H.L. Fehm, Night-time plasma cortisol secretion is associated with specific sleep stages, Biol. Psychiatry 21 (1986) 1415-1424.
5. J.J. Bouyer, J.M. Deminière, W. Mayo, M. Le Moal, Inter-individual differences in the effects of acute stress on the sleep-wakefulness cycle in the rat, Neurosci. Lett. 225 (1997) 193-196.
6. B.J. Bowers, J.M. Wehner, Adrenalectomy and stress modulate GABAA receptor function in LS and SS mice, Brain Res. 576 (1992) 80-88.
7. R.J. Carey, M. Pinheiro-Carrera, H. Dai, C. Tomaz, J.P. Huston, L-DOPA and psychosis: evidence for L-DOPA-induced increases in prefrontal cortex dopamine and in serum corticosterone, Biol. Psychiatry 38 (1995) 669-676.
8. R. Cespuglio, S. Marinesco, G. Baubet, C. Bonnet, B. el kafi, Evidence for a sleep-promoting influence of stress, Adv. Neuroimmunol. 5 (1995) 145-154.
9. R. Cespuglio, N. Sarda, A. Gharib, N. Chastrette, F. Houdouin, C. Rampin, M. Jouvet, Voltammetric detection of the release of 5-hydroxyindole compounds throughout the sleep-waking cycle of the rat, Exp. Brain Res. 80 (1990) 121-128.
10. N. Chastrette, R. Cespuglio, M. Jouvet, Proopiomelanocortin (POMC)-derived peptides and sleep in the rat: Part 1. Hypnogenic properties of ACTH derivatives, Neuropeptides 15 (1990) 61-74.
11. A. Czyrak, K. Wedzony, B. Michalska, K. Fijal, M. Dziedzicka-Wasylewska, M. Mackowiak, The corticosterone synthesis inhibitor metyrapone decreases dopamine D1 receptors in the rat brain, Neuroscience 79 (1997) 489-495.
12. P. Dedeurwaedère, L. Stinus, U. Spampinato, Opposite changes of dopamine release in the rat striatum and nucleus accumbens following electrical stimulation of dorsal raphe neurons: involvement of endogenous serotonin, in: M. Mas (Ed.), Monitoring Molecules in Neurosciences, 1996, pp. 227-228.
13. F. Dellu, W. Mayo, M. Vallée, M. Le Moal, H. Simon, Reactivity to novelty during youth as a predictive factor of cognitive impairment in the elderly: a longitudinal study in rats, Brain Res. 653 (1994) 51-56.
14. M. Follenius, G. Brandenberger, J.J. Bandesapt, J.P. Libert, J. Ehrhart, Nocturnal cortisol release in relation to sleep structure, Sleep 15 (1992) 21-27.
15. J.C. Gillin, L.S. Jacobs, D.H. Fram, F. Snyder, Acute effect of a glucocorticoid on normal human sleep, Nature 237 (1972) 398-399.
16. M.M. Gonzalez, J.L. Valatx, Effect of intracerebroventricular administration of α-helical CRH (9-41) on the sleep/waking cycle in rats under normal conditions or after subjection to an acute stressful stimulus, J. Sleep Res. 6 (1997) 164-170.
17. C. Gottesmann, Detection of seven sleep-waking stages in the rat, Neurosci. Biobehav. Rev. 16 (1992) 31-38.
18. R.A. Hicks, E.R. Garcia, Level of stress and sleep duration, Percept. Mot. Skills. 64 (1987) 44-46.
19. R.A. Hicks, S. McTighe, M. Juarez, Sleep duration and eating behaviors of college students, Percept. Mot. Skills 62 (1986) 25-26.
20. R.A. Hicks, E. Rozette, Habitual sleep duration and eating disorders in college students, Percept. Mot. Skills 62 (1986) 209-210.
21. T. Inoue, T. Koyama, Effects of acute and chronic administration of high-dose corticosterone and dexamethasone on regional brain dopamine and serotonin metabolism in rats, Prog. Neuropsychopharmacol. Biol. Psychiatry 20 (1996) 147-156.
22. G.A. Kerkohf, Inter-individual differences in the human circadian system: a review, J. Appl. Physiol. 79 (1985) 1461-1468.
23. M. Kern, B. Perras, R. Wodick, H.L. Fehm, J. Born, Hormonal secretion during nighttime sleep indicating stress of daytime exercise, J. Appl. Physiol. 79 (1995) 1461-1468.
24. S. Maccari, P.V. Piazza, J.M. Deminière, L. Angelucci, H. Simon, M. Le Moal, Hippocampal type I and type II receptor affinities are reduced in rats predisposed to develop amphetamine self-administration, Brain Res. 548 (1991) 305-309.
25. P. Mandile, S. Vescia, P. Montagnese, F. Romano, A. Giuditta, Characterization of transition sleep episodes in baseline EEG recordings of adult rats, Physiol. Behav. 60 (1996) 1435-1436.
26. N. Mitsugi, F. Kimura, Simultaneous determination of blood levels of corticosterone and growth hormone in the male rat: relation to sleep-wakefulness cycle, Neuroendocrinology 41 (1985) 125-130.
27. J.M. Monti, M. Hawkins, H. Jantos, L. D'Angelo, M. Fernandez, Biphasic effects of dopamine D-2 receptor agonists on sleep and wakefulness in the rat, Psychopharmacology (Berlin) 95 (1988) 395-400.
28. J.M. Monti, H. Jantos, M. Fernandez, Effects of the selective dopamine D-2 receptor agonist, quinpirole on sleep and wakefulness in the rat, Eur. J. Pharmacol. 169 (1989) 61-66.
29. M.R. Opp, Corticotropin-releasing hormone involvement in stressor-induced alterations in sleep and in the regulation of waking, Adv. Neuroimmunol. 5 (1995) 127-143.
30. P.V. Piazza, M. Barrot, M. Marinelli, S. Maccari, D.N. Abrous, H. Simon, Suppression of glucocorticoid secretion and antipsychotic drugs have similar effects on the mesolimbic dopaminergic transmission, Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 15445-15450.
31. P.V. Piazza, J.M. Deminière, S. Maccari, P. Mormède, M. Le Moal, H. Simon, Individual reactivity to novelty predicts probability of amphetamine self-administration, Biol. Pharmacol. 1 (1990) 339-345.
32. P.V. Piazza, M. Le Moal, Pathophysiological basis of vulnerability to drug abuse: role of an interaction between stress, glucocorticoids, and dopaminergic neurons, Annu. Rev. Pharmacol. Toxicol. 36 (1996) 359-378.
33. P.V. Piazza, S. Maccari, J.M. Deminière, M. Le Moal, P. Mormède, H. Simon, Corticosterone levels determine individual vulnerability to amphetamine self-administration, Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 2088-2092.
34. P.V. Piazza, F. Rougé-Pont, J.M. Deminière, M. Kharoubi, M. Le Moal, H. Simon, Dopamine activity is reduced in the prefrontal cortex and increased in the nucleus accumbens of rats predisposed to develop amphetamine self-administration, Brain Res. 567 (1991) 169-174.
35. A. Ponzoni, J.M. Monti, H. Jantos, H. Altier, D. Monti, Increased waking after intra-accumbens injection of m-chlorophenylbiguanide: prevention with serotonin or dopamine receptor antagonists, Eur. J. Pharmacol. 278 (1995) 111-115.
36. C. Rampin, R. Cespuglio, N. Chastrette, M. Jouvet, Immbilization stress induces a paradoxical sleep rebound in rat, Neurosci. Lett. 126 (1991) 113-118.
37. W. Rostene, A. Sarrieau, A. Nicot, V. Scarceriaux, C. Betancur, D. Gully, M. Meaney, W. Rowe, K.R. De, D. Pelaprat, Steroid effects on brain functions: an example of the action of glucocorticoids on central dopaminergic and neurotensinergic systems, J. Psychiatry Neurosci. 20 (1995) 349-356.
38. F. Rougé-Pont, P.V. Piazza, M. Kharoubi, M. Le Moal, H. Simon, Higher and longer stress-induced increase in dopamine concentrations in the nucleus accumbens of animals predisposed to amphetamine self-administration. A microdialysis study, Brain Res. 602 (1993) 169-174.
39. M. Sallanon, C. Buda, M. Janin, M. Jouvet, Serotoninergic mechanisms and sleep rebound, Brain Res. 268 (1983) 95-104.
40. P.G. Smelick, F. Berkenbosh, I. Vermes, F.G.H. Tilders, Stress-induced release of proopiomelanocortin derived peptides from the anterior and intermediate lobe of the rat pituitary, in: A.I. Baertschi, S.S. Dreiffus (Eds.), Neuroendocrinology of vasopressin, corticoliberin and opiomelanocortins, Academic Press, London, 1982, pp. 297-306.
41. C. Timo-Iara, N. Negrão, W.R. Schmidek, K. Hoshino, C.E. Lobato de Menezes, T. Leme da Rocha, Phases and states of sleep in the rat, Physiol. Behav. 5 (1970) 1062.
42. M. Trampus, N. Ferri, A. Monopoli, E. Ongini, The dopamine D1 receptor is involved in the regulation of REM sleep in the rat, Eur. J. Pharmacol. 194 (1991) 189-194.
43. M. Trampus, E. Ongini, The D1 dopamine receptor antagonist SCH 23390 enhances REM sleep in the rat, Neuropharmacology 29 (1990) 889-893.
44. L. Weibel, M. Follenius, K. Spiegel, J. Ehrhart, G. Brandenberger, Comparative effect of night and daytime sleep on the 24-hour cortisol secretory profile, Sleep 18 (1995) 549-556.
45. K. Wiedemann, C. Lauer, T. Pollmächer, F. Holsboer, Sleep endocrine effects of antigluco- and antimineralocorticoids in healthy males, Am. J. Physiol. 267 (1994) E109-114.